Overview

Indomethacin and Cardiac Bypass Surgery

Status:
Completed
Trial end date:
2002-04-01
Target enrollment:
Participant gender:
Summary
Following signed informed consent, patients scheduled for elective cardiac surgery were randomly assigned to one of 3 groups to be given acetaminophen, Indomethacin or a combination of both immediately following induction and then at 6, 12, 18 & 24 hours following surgery. Our primary outcome measure was the amount of blood drained from the mediastinal tubes and chest drains. Secondary outcome measures included conventional blood coagulation indices as well as other measures of clotting as indicated by thromboelastography (TEG). Other secondary outcome measures included consumption of morphine equivalents and pain scores.
Phase:
Phase 4
Details
Lead Sponsor:
Queen's University
Treatments:
Acetaminophen
Indomethacin
Polystyrene sulfonic acid